Lyka Labs is currently trading at Rs 84.50, up by 1.80 points or 2.18% from its previous closing of Rs 82.70 on the BSE.
The scrip opened at Rs. 83.30 and has touched a high and low of Rs. 86.15 and Rs. 82.00 respectively. So far 47134 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 142.90 on 26-Nov-2015 and a 52 week low of Rs. 50.25 on 28-Apr-2015.
Last one week high and low of the scrip stood at Rs. 85.50 and Rs. 78.70 respectively. The current market cap of the company is Rs. 183.59 crore.
The promoters holding in the company stood at 24.90% while Institutions and Non-Institutions held 0.84% and 74.27% respectively.
Lyka Healthcare, a wholly owned subsidiary of Lyka Labs, has launched two domestic marketing divisions in the name of Enspan and Cerabelle. Enspan would be marketing Critical and Anesthesia range of Products and Cerabelle would be marketing Dermatology and Cosmetology range of Products. The said products would also be offered internationally in the 46 countries in which Lyka has its presence.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |